3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Breast
1
Conditions
Inflammation
2
Breast Neoplasms
2
Obesity
1
Curative Breast Cancer Surgery
1
Interventions
Exercise
8
exemestane
3
Tamoxifen
3
Methods
3
Metformin
3
Early Intervention, Educational
3
Diet Therapy
3
Vitamin D
2
Sugars
2
Specimen Handling
2
Naltrexone
2
Mammography
2
Letrozole
2
Diet, Mediterranean
2
Counseling
2
Cognitive Behavioral Therapy
2
Cholecalciferol
2
Bupropion
2
Blood Specimen Collection
2
Bariatric Surgery
2
Anastrozole
2
rosiglitazone-metformin combination
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Yoga
1
Walking
1
Tirzepatide
1
Tablets
1
TOPS
1
Soybean Proteins
1
Rosiglitazone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Obesity
×
Ketorolac
×
Breast
×
Clear all
NCT06150898
2025-06-13
KePreSt
Jules Bordet Institute
Phase 2
Recruiting
112 enrolled